Bath & Body Works (NYSE:BBWI) Issues Quarterly Earnings Results

Bath & Body Works (NYSE:BBWI – Get Free Report) released its quarterly earnings results on Thursday. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.14, FiscalAI reports. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.55 billion. During the same quarter last year, the firm earned $0.37 earnings per share. The company’s revenue for the quarter was down 1.1% on a year-over-year basis. Bath & Body Works updated its Q4 2026 guidance to 1.410-1.610 EPS and its FY 2026 guidance to 2.600-2.800 EPS.

Here are the key takeaways from Bath & Body Works’ conference call:

  • Third-quarter results beat expectations: sales declined 1%, versus guidance for a 2.5% to 5% decline, and adjusted EPS was $0.26, above the $0.07–$0.12 outlook. The company raised its full-year sales outlook to a 2.1%–3.4% decline but maintained adjusted EPS guidance of $2.60–$2.80.
  • Management said new product franchises—including Essentials, Everyday Luxuries and Reserve—are exceeding expectations, attracting repeat customers and supporting premium average selling prices. The company aims for these franchises to reach a high-single-digit share of global retail sales in 2027, though limited availability has constrained sales so far.
  • Digital sales grew for a second consecutive quarter, with improving conversion and customer recruitment; Amazon, Ulta and international operations also showed momentum. Management views these channels as opportunities to reach new customers, while saying stores remain an area for improvement.
  • Management cited pressured store traffic, weak Halloween results and underperforming body care, alongside a challenging consumer and competitive environment. Fourth-quarter sales are forecast to decline 2%–5.5%, and gross margin faces tariff and crude-oil cost pressures; the company said its return-to-growth goal remains 2027.

Bath & Body Works Stock Performance

Shares of BBWI stock opened at $18.93 on Friday. The company has a market cap of $3.82 billion, a P/E ratio of 4.93, a PEG ratio of 0.93 and a beta of 1.31. The stock has a 50 day simple moving average of $19.24 and a two-hundred day simple moving average of $19.77. Bath & Body Works has a fifty-two week low of $14.27 and a fifty-two week high of $24.94.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 4th. Investors of record on Friday, November 20th will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, November 20th. This represents a $0.80 annualized dividend and a yield of 4.2%. Bath & Body Works’s dividend payout ratio (DPR) is currently 20.83%.

Bath & Body Works News Roundup

Here’s some of the latest news about BBWI:

  • Positive Sentiment: Third-quarter adjusted earnings of $0.26 per share topped the $0.12 consensus estimate, while revenue of $1.58 billion also exceeded expectations. The company raised its full-year sales outlook, now projecting a decline of 3.4% to 2.1%. Q3 results and outlook
  • Positive Sentiment: A new $500 million share-repurchase authorization may support shareholder returns. Management also cited progress in digital and wholesale sales, while its Fuel for Growth program is expected to generate $200 million in cost savings. Long-term investor takeaways
  • Neutral Sentiment: A limited-edition holiday fragrance collection with Pantone adds a new gifting and home-products offering, though its sales impact is not yet clear. Pantone holiday collection

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on BBWI shares. Wells Fargo & Company upped their price target on Bath & Body Works from $24.00 to $25.00 and gave the company an “overweight” rating in a research report on Thursday, October 29th. Morgan Stanley lowered their price objective on Bath & Body Works from $22.00 to $20.00 and set an “equal weight” rating for the company in a research report on Thursday, August 27th. BMO Capital Markets started coverage on Bath & Body Works in a research note on Tuesday, September 8th. They issued a “market perform” rating and a $20.00 price objective on the stock. Jefferies Financial Group reiterated a “hold” rating and issued a $21.00 target price on shares of Bath & Body Works in a report on Thursday. Finally, Citigroup raised shares of Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 target price for the company in a research report on Tuesday, August 18th. Three investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Bath & Body Works currently has an average rating of “Hold” and a consensus price target of $22.40.

View Our Latest Report on BBWI

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.

Further Reading

Earnings History for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.